Literature DB >> 26771933

RECENT ADVANCES IN BIOMARKERS IN SEVERE BURNS.

Mireia Ruiz-Castilla1, Oriol Roca, Joan R Masclans, Joan P Barret.   

Abstract

The pathophysiology of burn injuries is tremendously complex. A thorough understanding is essential for correct treatment of the burned area and also to limit the appearance of organ dysfunction, which, in fact, is a key determinant of morbidity and mortality. In this context, research into biomarkers may play a major role. Biomarkers have traditionally been considered an important area of medical research: the measurement of certain biomarkers has led to a better understanding of pathophysiology, while others have been used either to assess the effectiveness of specific treatments or for prognostic purposes. Research into biomarkers may help to improve the prognosis of patients with severe burn injury. The aim of the present clinical review is to discuss new evidence of the value of biomarkers in this setting.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26771933     DOI: 10.1097/SHK.0000000000000497

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  8 in total

1. 

Authors:  R Le Floch
Journal:  Ann Burns Fire Disasters       Date:  2017-09-30

2.  The clinical significance of the MIF homolog d-dopachrome tautomerase (MIF-2) and its circulating receptor (sCD74) in burn.

Authors:  Bong-Sung Kim; Christian Stoppe; Gerrit Grieb; Lin Leng; Maor Sauler; David Assis; David Simons; Arne Hendrick Boecker; Wibke Schulte; Marta Piecychna; Stephan Hager; Jürgen Bernhagen; Norbert Pallua; Richard Bucala
Journal:  Burns       Date:  2016-05-18       Impact factor: 2.744

Review 3.  Burn-Induced Coagulopathies: a Comprehensive Review.

Authors:  Robert L Ball; John W Keyloun; Kathleen Brummel-Ziedins; Thomas Orfeo; Tina L Palmieri; Laura S Johnson; Lauren T Moffatt; Anthony E Pusateri; Jeffrey W Shupp
Journal:  Shock       Date:  2020-08       Impact factor: 3.533

4.  Trends in microbial profile of burn patients following an event of dust explosion at a tertiary medical center.

Authors:  Yin-Yin Chen; Ping-Feng Wu; Chii-Shya Chen; Ian-Horng Chen; Wan-Tsuei Huang; Fu-Der Wang
Journal:  BMC Infect Dis       Date:  2020-03-04       Impact factor: 3.090

Review 5.  On the Nonspecific Resistance in Burn Injury: Pathophysiological Aspects (Review).

Authors:  A V Pereshein; S V Kuznetsova; O N Shevantaeva
Journal:  Sovrem Tekhnologii Med       Date:  2020-06-28

6.  Differential regulation of innate immune cytokine production through pharmacological activation of Nuclear Factor-Erythroid-2-Related Factor 2 (NRF2) in burn patient immune cells and monocytes.

Authors:  Timothy K Eitas; Wesley H Stepp; Lucas Sjeklocha; Clayton V Long; Caitlin Riley; James Callahan; Yolanda Sanchez; Peter Gough; Laquanda Knowlin; David van Duin; Shiara Ortiz-Pujols; Samuel W Jones; Robert Maile; Zhi Hong; Scott Berger; Bruce A Cairns
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

7.  Checking procalcitonin suitability for prognosis and antimicrobial therapy monitoring in burn patients.

Authors:  Luís Cabral; Vera Afreixo; Rita Meireles; Miguel Vaz; Catarina Chaves; Marisa Caetano; Luís Almeida; José Artur Paiva
Journal:  Burns Trauma       Date:  2018-03-31

8.  Procalcitonin kinetics after burn injury and burn surgery in septic and non-septic patients - a retrospective observational study.

Authors:  Luís Cabral; Vera Afreixo; Rita Meireles; Miguel Vaz; Margarida Marques; Isabel Tourais; Catarina Chaves; Luís Almeida; José Artur Paiva
Journal:  BMC Anesthesiol       Date:  2018-09-05       Impact factor: 2.217

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.